Mercer Global Advisors
BBNX

Mercer Global Advisors’s Beta Bionics BBNX Stock Holding History

Mercer Global Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
+8,811
New +$105K ﹤0.01% 3577

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Mercer Global Advisors's BBNX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Beta Bionics (BBNX) in Q2 2026: 8,811 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #3577 among its holdings.

123 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Mercer Global Advisors held 8,811 shares of Beta Bionics worth $138K as of Q2 2026.
  • Beta Bionics was a new Mercer Global Advisors position in Q2 2026.
  • Beta Bionics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3577 holding.
  • 123 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.